Article
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
International journal of cancer - 15 Oct 2014
Markkula Andrea, Simonsson Maria, Rosendahl Ann H, Gaber Alexander, Ingvar Christian, Rose Carsten, Jernström Helena
Abstract excerpt
The COX2 rs5277 (306G>C) polymorphism has been associated with inflammation-associated cancers. In breast cancer, tumor COX-2 expression has been associated with increased estrogen levels in estrogen receptor (ER)-positive and activated Akt-pathway in ER-negative tumors. Our study investigated the impact of COX2 genotypes on early breast cancer events and treatment response in relation to tumor ER status and body...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
